ID   MRP4_RAT                Reviewed;        1325 AA.
AC   F1M3J4; Q6QMG6;
DT   07-APR-2021, integrated into UniProtKB/Swiss-Prot.
DT   22-JUL-2015, sequence version 3.
DT   02-OCT-2024, entry version 89.
DE   RecName: Full=ATP-binding cassette subfamily C member 4;
DE            EC=7.6.2.- {ECO:0000250|UniProtKB:O15439};
DE            EC=7.6.2.2 {ECO:0000250|UniProtKB:O15439};
DE            EC=7.6.2.3 {ECO:0000250|UniProtKB:O15439};
DE   AltName: Full=Multidrug resistance-associated protein 4;
GN   Name=Abcc4 {ECO:0000312|RGD:620266};
GN   Synonyms=Mrp4 {ECO:0000303|PubMed:15047146};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND TISSUE SPECIFICITY.
RC   STRAIN=Sprague-Dawley;
RX   PubMed=15047146; DOI=10.1016/j.bbrc.2004.03.014;
RA   Chen C., Klaassen C.D.;
RT   "Rat multidrug resistance protein 4 (Mrp4, Abcc4): molecular cloning, organ
RT   distribution, postnatal renal expression, and chemical inducibility.";
RL   Biochem. Biophys. Res. Commun. 317:46-53(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Brown Norway;
RX   PubMed=15057822; DOI=10.1038/nature02426;
RA   Gibbs R.A., Weinstock G.M., Metzker M.L., Muzny D.M., Sodergren E.J.,
RA   Scherer S., Scott G., Steffen D., Worley K.C., Burch P.E., Okwuonu G.,
RA   Hines S., Lewis L., Deramo C., Delgado O., Dugan-Rocha S., Miner G.,
RA   Morgan M., Hawes A., Gill R., Holt R.A., Adams M.D., Amanatides P.G.,
RA   Baden-Tillson H., Barnstead M., Chin S., Evans C.A., Ferriera S.,
RA   Fosler C., Glodek A., Gu Z., Jennings D., Kraft C.L., Nguyen T.,
RA   Pfannkoch C.M., Sitter C., Sutton G.G., Venter J.C., Woodage T., Smith D.,
RA   Lee H.-M., Gustafson E., Cahill P., Kana A., Doucette-Stamm L.,
RA   Weinstock K., Fechtel K., Weiss R.B., Dunn D.M., Green E.D.,
RA   Blakesley R.W., Bouffard G.G., De Jong P.J., Osoegawa K., Zhu B., Marra M.,
RA   Schein J., Bosdet I., Fjell C., Jones S., Krzywinski M., Mathewson C.,
RA   Siddiqui A., Wye N., McPherson J., Zhao S., Fraser C.M., Shetty J.,
RA   Shatsman S., Geer K., Chen Y., Abramzon S., Nierman W.C., Havlak P.H.,
RA   Chen R., Durbin K.J., Egan A., Ren Y., Song X.-Z., Li B., Liu Y., Qin X.,
RA   Cawley S., Cooney A.J., D'Souza L.M., Martin K., Wu J.Q.,
RA   Gonzalez-Garay M.L., Jackson A.R., Kalafus K.J., McLeod M.P.,
RA   Milosavljevic A., Virk D., Volkov A., Wheeler D.A., Zhang Z., Bailey J.A.,
RA   Eichler E.E., Tuzun E., Birney E., Mongin E., Ureta-Vidal A., Woodwark C.,
RA   Zdobnov E., Bork P., Suyama M., Torrents D., Alexandersson M., Trask B.J.,
RA   Young J.M., Huang H., Wang H., Xing H., Daniels S., Gietzen D., Schmidt J.,
RA   Stevens K., Vitt U., Wingrove J., Camara F., Mar Alba M., Abril J.F.,
RA   Guigo R., Smit A., Dubchak I., Rubin E.M., Couronne O., Poliakov A.,
RA   Huebner N., Ganten D., Goesele C., Hummel O., Kreitler T., Lee Y.-A.,
RA   Monti J., Schulz H., Zimdahl H., Himmelbauer H., Lehrach H., Jacob H.J.,
RA   Bromberg S., Gullings-Handley J., Jensen-Seaman M.I., Kwitek A.E.,
RA   Lazar J., Pasko D., Tonellato P.J., Twigger S., Ponting C.P., Duarte J.M.,
RA   Rice S., Goodstadt L., Beatson S.A., Emes R.D., Winter E.E., Webber C.,
RA   Brandt P., Nyakatura G., Adetobi M., Chiaromonte F., Elnitski L.,
RA   Eswara P., Hardison R.C., Hou M., Kolbe D., Makova K., Miller W.,
RA   Nekrutenko A., Riemer C., Schwartz S., Taylor J., Yang S., Zhang Y.,
RA   Lindpaintner K., Andrews T.D., Caccamo M., Clamp M., Clarke L., Curwen V.,
RA   Durbin R.M., Eyras E., Searle S.M., Cooper G.M., Batzoglou S., Brudno M.,
RA   Sidow A., Stone E.A., Payseur B.A., Bourque G., Lopez-Otin C., Puente X.S.,
RA   Chakrabarti K., Chatterji S., Dewey C., Pachter L., Bray N., Yap V.B.,
RA   Caspi A., Tesler G., Pevzner P.A., Haussler D., Roskin K.M., Baertsch R.,
RA   Clawson H., Furey T.S., Hinrichs A.S., Karolchik D., Kent W.J.,
RA   Rosenbloom K.R., Trumbower H., Weirauch M., Cooper D.N., Stenson P.D.,
RA   Ma B., Brent M., Arumugam M., Shteynberg D., Copley R.R., Taylor M.S.,
RA   Riethman H., Mudunuri U., Peterson J., Guyer M., Felsenfeld A., Old S.,
RA   Mockrin S., Collins F.S.;
RT   "Genome sequence of the Brown Norway rat yields insights into mammalian
RT   evolution.";
RL   Nature 428:493-521(2004).
RN   [3]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
RN   [4]
RP   SUBCELLULAR LOCATION.
RX   PubMed=12883481; DOI=10.1053/jhep.2003.50331;
RA   Rius M., Nies A.T., Hummel-Eisenbeiss J., Jedlitschky G., Keppler D.;
RT   "Cotransport of reduced glutathione with bile salts by MRP4 (ABCC4)
RT   localized to the basolateral hepatocyte membrane.";
RL   Hepatology 38:374-384(2003).
CC   -!- FUNCTION: ATP-dependent transporter of the ATP-binding cassette (ABC)
CC       family that actively extrudes physiological compounds and xenobiotics
CC       from cells. Transports a range of endogenous molecules that have a key
CC       role in cellular communication and signaling, including cyclic
CC       nucleotides such as cyclic AMP (cAMP) and cyclic GMP (cGMP), bile
CC       acids, steroid conjugates, urate, and prostaglandins. Mediates also the
CC       ATP-dependent efflux of glutathione conjugates such as leukotriene C4
CC       (LTC4) and leukotriene B4 (LTB4). The presence of GSH is necessary for
CC       the ATP-dependent transport of LTB4, whereas GSH is not required for
CC       the transport of LTC4. Mediates the cotransport of bile acids with
CC       reduced glutathione (GSH). Transports a wide range of drugs and their
CC       metabolites, including anticancer, antiviral and antibiotics molecules.
CC       {ECO:0000250|UniProtKB:O15439}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + H2O + xenobioticSide 1 = ADP + phosphate +
CC         xenobioticSide 2.; EC=7.6.2.2;
CC         Evidence={ECO:0000250|UniProtKB:O15439};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=an S-substituted glutathione(in) + ATP + H2O = ADP + an S-
CC         substituted glutathione(out) + H(+) + phosphate;
CC         Xref=Rhea:RHEA:19121, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:43474, ChEBI:CHEBI:90779,
CC         ChEBI:CHEBI:456216; EC=7.6.2.3;
CC         Evidence={ECO:0000250|UniProtKB:O15439};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:19122;
CC         Evidence={ECO:0000250|UniProtKB:O15439};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=17beta-estradiol 17-O-(beta-D-glucuronate)(in) + ATP + H2O =
CC         17beta-estradiol 17-O-(beta-D-glucuronate)(out) + ADP + H(+) +
CC         phosphate; Xref=Rhea:RHEA:60128, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, ChEBI:CHEBI:43474,
CC         ChEBI:CHEBI:82961, ChEBI:CHEBI:456216;
CC         Evidence={ECO:0000250|UniProtKB:O15439};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:60129;
CC         Evidence={ECO:0000250|UniProtKB:O15439};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + dehydroepiandrosterone 3-sulfate(in) + H2O = ADP +
CC         dehydroepiandrosterone 3-sulfate(out) + H(+) + phosphate;
CC         Xref=Rhea:RHEA:61364, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:43474, ChEBI:CHEBI:57905,
CC         ChEBI:CHEBI:456216; Evidence={ECO:0000250|UniProtKB:O15439};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:61365;
CC         Evidence={ECO:0000250|UniProtKB:O15439};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + H2O + leukotriene C4(in) = ADP + H(+) + leukotriene
CC         C4(out) + phosphate; Xref=Rhea:RHEA:38963, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, ChEBI:CHEBI:43474,
CC         ChEBI:CHEBI:57973, ChEBI:CHEBI:456216;
CC         Evidence={ECO:0000250|UniProtKB:O15439};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:38964;
CC         Evidence={ECO:0000250|UniProtKB:O15439};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + H2O + leukotriene B4(in) = ADP + H(+) + leukotriene
CC         B4(out) + phosphate; Xref=Rhea:RHEA:66424, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, ChEBI:CHEBI:43474,
CC         ChEBI:CHEBI:57461, ChEBI:CHEBI:456216;
CC         Evidence={ECO:0000250|UniProtKB:O15439};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + H2O + urate(in) = ADP + H(+) + phosphate + urate(out);
CC         Xref=Rhea:RHEA:16461, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:17775, ChEBI:CHEBI:30616, ChEBI:CHEBI:43474,
CC         ChEBI:CHEBI:456216; Evidence={ECO:0000250|UniProtKB:O15439};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:16462;
CC         Evidence={ECO:0000250|UniProtKB:O15439};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=3',5'-cyclic GMP(in) + ATP + H2O = 3',5'-cyclic GMP(out) + ADP
CC         + H(+) + phosphate; Xref=Rhea:RHEA:66188, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, ChEBI:CHEBI:43474,
CC         ChEBI:CHEBI:57746, ChEBI:CHEBI:456216;
CC         Evidence={ECO:0000250|UniProtKB:O15439};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:66189;
CC         Evidence={ECO:0000250|UniProtKB:O15439};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=3',5'-cyclic AMP(in) + ATP + H2O = 3',5'-cyclic AMP(out) + ADP
CC         + H(+) + phosphate; Xref=Rhea:RHEA:66184, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, ChEBI:CHEBI:43474,
CC         ChEBI:CHEBI:58165, ChEBI:CHEBI:456216;
CC         Evidence={ECO:0000250|UniProtKB:O15439};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:66185;
CC         Evidence={ECO:0000250|UniProtKB:O15439};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + H2O + prostaglandin E2(in) = ADP + H(+) + phosphate +
CC         prostaglandin E2(out); Xref=Rhea:RHEA:66388, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, ChEBI:CHEBI:43474,
CC         ChEBI:CHEBI:456216, ChEBI:CHEBI:606564;
CC         Evidence={ECO:0000250|UniProtKB:O15439};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:66389;
CC         Evidence={ECO:0000250|UniProtKB:O15439};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + H2O + prostaglandin E1(in) = ADP + H(+) + phosphate +
CC         prostaglandin E1(out); Xref=Rhea:RHEA:66392, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, ChEBI:CHEBI:43474,
CC         ChEBI:CHEBI:57397, ChEBI:CHEBI:456216;
CC         Evidence={ECO:0000250|UniProtKB:O15439};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:66393;
CC         Evidence={ECO:0000250|UniProtKB:O15439};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + glutathione(in) + glycodeoxycholate(in) + H2O = ADP +
CC         glutathione(out) + glycodeoxycholate(out) + H(+) + phosphate;
CC         Xref=Rhea:RHEA:66380, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:43474, ChEBI:CHEBI:57925,
CC         ChEBI:CHEBI:82982, ChEBI:CHEBI:456216;
CC         Evidence={ECO:0000250|UniProtKB:O15439};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:66381;
CC         Evidence={ECO:0000250|UniProtKB:O15439};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + cholate(in) + glutathione(in) + H2O = ADP + cholate(out)
CC         + glutathione(out) + H(+) + phosphate; Xref=Rhea:RHEA:66396,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:29747,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:43474, ChEBI:CHEBI:57925,
CC         ChEBI:CHEBI:456216; Evidence={ECO:0000250|UniProtKB:O15439};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:66397;
CC         Evidence={ECO:0000250|UniProtKB:O15439};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + glutathione(in) + glycocholate(in) + H2O = ADP +
CC         glutathione(out) + glycocholate(out) + H(+) + phosphate;
CC         Xref=Rhea:RHEA:66400, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:29746, ChEBI:CHEBI:30616, ChEBI:CHEBI:43474,
CC         ChEBI:CHEBI:57925, ChEBI:CHEBI:456216;
CC         Evidence={ECO:0000250|UniProtKB:O15439};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:66401;
CC         Evidence={ECO:0000250|UniProtKB:O15439};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + glutathione(in) + H2O + taurocholate(in) = ADP +
CC         glutathione(out) + H(+) + phosphate + taurocholate(out);
CC         Xref=Rhea:RHEA:66404, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:36257, ChEBI:CHEBI:43474,
CC         ChEBI:CHEBI:57925, ChEBI:CHEBI:456216;
CC         Evidence={ECO:0000250|UniProtKB:O15439};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:66405;
CC         Evidence={ECO:0000250|UniProtKB:O15439};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + glutathione(in) + glycochenodeoxycholate(in) + H2O = ADP
CC         + glutathione(out) + glycochenodeoxycholate(out) + H(+) + phosphate;
CC         Xref=Rhea:RHEA:66408, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:36252, ChEBI:CHEBI:43474,
CC         ChEBI:CHEBI:57925, ChEBI:CHEBI:456216;
CC         Evidence={ECO:0000250|UniProtKB:O15439};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:66409;
CC         Evidence={ECO:0000250|UniProtKB:O15439};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + glutathione(in) + H2O + taurochenodeoxycholate(in) = ADP
CC         + glutathione(out) + H(+) + phosphate + taurochenodeoxycholate(out);
CC         Xref=Rhea:RHEA:66412, ChEBI:CHEBI:9407, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, ChEBI:CHEBI:43474,
CC         ChEBI:CHEBI:57925, ChEBI:CHEBI:456216;
CC         Evidence={ECO:0000250|UniProtKB:O15439};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:66413;
CC         Evidence={ECO:0000250|UniProtKB:O15439};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + glutathione(in) + glycoursodeoxycholate(in) + H2O = ADP
CC         + glutathione(out) + glycoursodeoxycholate(out) + H(+) + phosphate;
CC         Xref=Rhea:RHEA:66416, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:43474, ChEBI:CHEBI:57925,
CC         ChEBI:CHEBI:132030, ChEBI:CHEBI:456216;
CC         Evidence={ECO:0000250|UniProtKB:O15439};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:66417;
CC         Evidence={ECO:0000250|UniProtKB:O15439};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + glutathione(in) + H2O + tauroursodeoxycholate(in) = ADP
CC         + glutathione(out) + H(+) + phosphate + tauroursodeoxycholate(out);
CC         Xref=Rhea:RHEA:66420, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:43474, ChEBI:CHEBI:57925,
CC         ChEBI:CHEBI:132028, ChEBI:CHEBI:456216;
CC         Evidence={ECO:0000250|UniProtKB:O15439};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:66421;
CC         Evidence={ECO:0000250|UniProtKB:O15439};
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000250|UniProtKB:O15439};
CC   -!- SUBUNIT: Interacts (via PDZ-binding motif) with SNX27 (via PDZ domain);
CC       this interaction accelerates MRP4 internalization.
CC       {ECO:0000250|UniProtKB:O15439}.
CC   -!- SUBCELLULAR LOCATION: Basolateral cell membrane
CC       {ECO:0000269|PubMed:12883481}; Multi-pass membrane protein
CC       {ECO:0000255}. Apical cell membrane {ECO:0000250|UniProtKB:O15439};
CC       Multi-pass membrane protein {ECO:0000255}. Note=Its localization to the
CC       basolateral or apical membranes is tissue-dependent.
CC       {ECO:0000250|UniProtKB:O15439}.
CC   -!- TISSUE SPECIFICITY: Ubiquitous with high levels in kidney.
CC       {ECO:0000269|PubMed:15047146}.
CC   -!- PTM: N-glycosylated; leading to substrate-selective effects on its
CC       transport activity. {ECO:0000250|UniProtKB:O15439}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY533524; AAS78928.1; -; mRNA.
DR   EMBL; AABR07019392; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AABR07019393; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AABR07019394; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AABR07019395; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; NP_596902.1; NM_133411.1.
DR   AlphaFoldDB; F1M3J4; -.
DR   SMR; F1M3J4; -.
DR   STRING; 10116.ENSRNOP00000033826; -.
DR   ChEMBL; CHEMBL2073711; -.
DR   iPTMnet; F1M3J4; -.
DR   PhosphoSitePlus; F1M3J4; -.
DR   jPOST; F1M3J4; -.
DR   PaxDb; 10116-ENSRNOP00000033826; -.
DR   PeptideAtlas; F1M3J4; -.
DR   GeneID; 170924; -.
DR   KEGG; rno:170924; -.
DR   AGR; RGD:620266; -.
DR   CTD; 10257; -.
DR   RGD; 620266; Abcc4.
DR   VEuPathDB; HostDB:ENSRNOG00000010064; -.
DR   eggNOG; KOG0054; Eukaryota.
DR   HOGENOM; CLU_000604_27_1_1; -.
DR   InParanoid; F1M3J4; -.
DR   OrthoDB; 3384185at2759; -.
DR   TreeFam; TF105202; -.
DR   BRENDA; 7.6.2.3; 5301.
DR   Reactome; R-RNO-114608; Platelet degranulation.
DR   Reactome; R-RNO-382556; ABC-family proteins mediated transport.
DR   Reactome; R-RNO-9748787; Azathioprine ADME.
DR   Reactome; R-RNO-9753281; Paracetamol ADME.
DR   PRO; PR:F1M3J4; -.
DR   Proteomes; UP000002494; Chromosome 15.
DR   Bgee; ENSRNOG00000010064; Expressed in adult mammalian kidney and 18 other cell types or tissues.
DR   ExpressionAtlas; F1M3J4; baseline and differential.
DR   GO; GO:0016324; C:apical plasma membrane; ISO:RGD.
DR   GO; GO:0016323; C:basolateral plasma membrane; IDA:ARUK-UCL.
DR   GO; GO:0098591; C:external side of apical plasma membrane; IDA:ARUK-UCL.
DR   GO; GO:0016020; C:membrane; ISO:RGD.
DR   GO; GO:0005886; C:plasma membrane; ISO:RGD.
DR   GO; GO:0031088; C:platelet dense granule membrane; ISO:RGD.
DR   GO; GO:0015432; F:ABC-type bile acid transporter activity; ISS:UniProtKB.
DR   GO; GO:0015431; F:ABC-type glutathione S-conjugate transporter activity; ISS:UniProtKB.
DR   GO; GO:0008559; F:ABC-type xenobiotic transporter activity; IEA:UniProtKB-EC.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0016887; F:ATP hydrolysis activity; IEA:InterPro.
DR   GO; GO:0042626; F:ATPase-coupled transmembrane transporter activity; ISS:UniProtKB.
DR   GO; GO:0015562; F:efflux transmembrane transporter activity; ISO:RGD.
DR   GO; GO:0034634; F:glutathione transmembrane transporter activity; ISS:UniProtKB.
DR   GO; GO:0001409; F:guanine nucleotide transmembrane transporter activity; ISS:UniProtKB.
DR   GO; GO:0015132; F:prostaglandin transmembrane transporter activity; ISS:UniProtKB.
DR   GO; GO:0015216; F:purine nucleotide transmembrane transporter activity; ISO:RGD.
DR   GO; GO:0015143; F:urate transmembrane transporter activity; ISS:UniProtKB.
DR   GO; GO:0042910; F:xenobiotic transmembrane transporter activity; ISS:UniProtKB.
DR   GO; GO:0015721; P:bile acid and bile salt transport; ISS:UniProtKB.
DR   GO; GO:0070730; P:cAMP transport; ISS:UniProtKB.
DR   GO; GO:0060271; P:cilium assembly; ISO:RGD.
DR   GO; GO:0140115; P:export across plasma membrane; ISO:RGD.
DR   GO; GO:0071716; P:leukotriene transport; ISS:UniProtKB.
DR   GO; GO:0048661; P:positive regulation of smooth muscle cell proliferation; IMP:RGD.
DR   GO; GO:0032310; P:prostaglandin secretion; ISO:RGD.
DR   GO; GO:0015732; P:prostaglandin transport; ISS:UniProtKB.
DR   GO; GO:0014070; P:response to organic cyclic compound; IEP:RGD.
DR   GO; GO:1904772; P:response to tetrachloromethane; IEP:RGD.
DR   GO; GO:0009410; P:response to xenobiotic stimulus; IEP:RGD.
DR   GO; GO:0055085; P:transmembrane transport; IBA:GO_Central.
DR   GO; GO:0015747; P:urate transport; ISS:UniProtKB.
DR   CDD; cd18593; ABC_6TM_MRP4_D1_like; 1.
DR   CDD; cd18601; ABC_6TM_MRP4_D2_like; 1.
DR   CDD; cd03250; ABCC_MRP_domain1; 1.
DR   CDD; cd03244; ABCC_MRP_domain2; 1.
DR   Gene3D; 1.20.1560.10; ABC transporter type 1, transmembrane domain; 2.
DR   Gene3D; 3.40.50.300; P-loop containing nucleotide triphosphate hydrolases; 2.
DR   InterPro; IPR003593; AAA+_ATPase.
DR   InterPro; IPR011527; ABC1_TM_dom.
DR   InterPro; IPR036640; ABC1_TM_sf.
DR   InterPro; IPR003439; ABC_transporter-like_ATP-bd.
DR   InterPro; IPR017871; ABC_transporter-like_CS.
DR   InterPro; IPR050173; ABC_transporter_C.
DR   InterPro; IPR030240; ABCC4_TMD1.
DR   InterPro; IPR047083; ABCC4_TMD2.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   PANTHER; PTHR24223; ATP-BINDING CASSETTE SUB-FAMILY C; 1.
DR   PANTHER; PTHR24223:SF357; ATP-BINDING CASSETTE SUB-FAMILY C MEMBER 4; 1.
DR   Pfam; PF00664; ABC_membrane; 2.
DR   Pfam; PF00005; ABC_tran; 2.
DR   SMART; SM00382; AAA; 2.
DR   SUPFAM; SSF90123; ABC transporter transmembrane region; 2.
DR   SUPFAM; SSF52540; P-loop containing nucleoside triphosphate hydrolases; 2.
DR   PROSITE; PS50929; ABC_TM1F; 2.
DR   PROSITE; PS00211; ABC_TRANSPORTER_1; 2.
DR   PROSITE; PS50893; ABC_TRANSPORTER_2; 2.
PE   1: Evidence at protein level;
KW   ATP-binding; Cell membrane; Lipid transport; Membrane; Nucleotide-binding;
KW   Reference proteome; Translocase; Transmembrane; Transmembrane helix;
KW   Transport.
FT   CHAIN           1..1325
FT                   /note="ATP-binding cassette subfamily C member 4"
FT                   /id="PRO_0000452320"
FT   TRANSMEM        93..113
FT                   /note="Helical"
FT                   /evidence="ECO:0000255, ECO:0000255|PROSITE-
FT                   ProRule:PRU00441"
FT   TRANSMEM        136..156
FT                   /note="Helical"
FT                   /evidence="ECO:0000255, ECO:0000255|PROSITE-
FT                   ProRule:PRU00441"
FT   TRANSMEM        205..225
FT                   /note="Helical"
FT                   /evidence="ECO:0000255, ECO:0000255|PROSITE-
FT                   ProRule:PRU00441"
FT   TRANSMEM        227..247
FT                   /note="Helical"
FT                   /evidence="ECO:0000255, ECO:0000255|PROSITE-
FT                   ProRule:PRU00441"
FT   TRANSMEM        322..342
FT                   /note="Helical"
FT                   /evidence="ECO:0000255, ECO:0000255|PROSITE-
FT                   ProRule:PRU00441"
FT   TRANSMEM        351..371
FT                   /note="Helical"
FT                   /evidence="ECO:0000255, ECO:0000255|PROSITE-
FT                   ProRule:PRU00441"
FT   TRANSMEM        710..730
FT                   /note="Helical"
FT                   /evidence="ECO:0000255, ECO:0000255|PROSITE-
FT                   ProRule:PRU00441"
FT   TRANSMEM        761..781
FT                   /note="Helical"
FT                   /evidence="ECO:0000255, ECO:0000255|PROSITE-
FT                   ProRule:PRU00441"
FT   TRANSMEM        836..856
FT                   /note="Helical"
FT                   /evidence="ECO:0000255, ECO:0000255|PROSITE-
FT                   ProRule:PRU00441"
FT   TRANSMEM        858..878
FT                   /note="Helical"
FT                   /evidence="ECO:0000255, ECO:0000255|PROSITE-
FT                   ProRule:PRU00441"
FT   TRANSMEM        954..974
FT                   /note="Helical"
FT                   /evidence="ECO:0000255, ECO:0000255|PROSITE-
FT                   ProRule:PRU00441"
FT   TRANSMEM        977..997
FT                   /note="Helical"
FT                   /evidence="ECO:0000255, ECO:0000255|PROSITE-
FT                   ProRule:PRU00441"
FT   DOMAIN          93..377
FT                   /note="ABC transmembrane type-1 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00441"
FT   DOMAIN          410..633
FT                   /note="ABC transporter 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00434"
FT   DOMAIN          715..1005
FT                   /note="ABC transmembrane type-1 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00441"
FT   DOMAIN          1041..1274
FT                   /note="ABC transporter 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00434"
FT   REGION          658..691
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         445..452
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00434"
FT   BINDING         1075..1082
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00434"
FT   CONFLICT        273
FT                   /note="I -> F (in Ref. 1; AAS78928)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        348
FT                   /note="A -> S (in Ref. 1; AAS78928)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        517
FT                   /note="F -> L (in Ref. 1; AAS78928)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        525..526
FT                   /note="RL -> LT (in Ref. 1; AAS78928)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        534
FT                   /note="R -> T (in Ref. 1; AAS78928)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        547
FT                   /note="T -> R (in Ref. 1; AAS78928)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   1325 AA;  148904 MW;  F9DBE9399C1502FE CRC64;
     MLPVHTEVKP NPLQDANLCS RLFFWWLNPL FKAGHKRRLE EDDMFSVLPE DRSKHLGEEL
     QGYWDKEVLR AKKDARKPSL TKAIVKCYWK SYLILGIFTL IEETTRVVQP IFLGKIIDYF
     EKYDSDDSAA LHTAYGYAAV LSLCTLILAI LHHLYFYHVQ CAGMRIRVAM CHMIYRKALR
     LSNSAMGKTT TGQIVNLLSN DVNKFDQVTI FLHFLWAGPL QAIGVTILLW VEIGISCLAG
     LAILVILLPL QSCIGKLFSS LRSKTAAFTD ARIRTMNEVI TGMRIIKMYA WEKSFADLIT
     NLRKKEISKI LGSSYLRGMN MASFFIANKV ILFVTFTTYV LLGNKITASH VFVAMTLYGA
     VRLTVTLFFP SAIERVSEAV VSVRRIKNFL LLDELPERKA QEPSDGKAIV HVQDFTAFWD
     KALDTPTLQG LSFTARPGEL LAVVGPVGAG KSSLLSAVLG ELPPTSGLVS VHGRIAYVSQ
     QPWVFSGTVR SNILFGRKYE KERYEKVIKA CALKKDFQLL EDGDRLVIGD RGARLSGGQK
     ARVNLATAVY QDADIYLLDD PLSAVDAEVG KHLFQLCICQ TLHEKITILV THQLQYLKAA
     SHILILKDGE MVQKGTYTEF LKSGVDFGSL LKKENEEAEP SPVPGTPTLR NRTFSEASIW
     SQQSSRPSLK DGVPDAQDAE NTQAAQPEES RSEGRIGFKA YKNYFSAGAS WFFIIFLVLL
     NLMGQVFYVL QDWWLSHWAN RQGALNDTKN ANGNVTGTLD LSWYLGIYTG LTAVTVLFGI
     ARSLLVFYVL VNASQTLHNR MFESILKAPV LFFDRNPIGR ILNRFSKDIG HMDDLLPLTF
     LDFIQTLLLV VSVIAVAAAV IPWILIPLVP LSIIFVVLRR YFLETSRDVK RLESTTRSPV
     FSHLSSSLQG LWTIRAYKAE ERCQELFDAH QDLHSEAWFL FLTTSRWFAV RLDAICAVFV
     IVVAFGSLVL AKTLDAGQVG LALSYSLTLM GMFQWSVRQS AEVENMMISV ERVIEYTDLE
     KEAPWECRKR PPPGWPHEGV IVFDNVNFTY SLDGPLVLKH LTALIKSREK VGIVGRTGAG
     KSSLISALFR LSEPEGKIWI DKILTTEIGL HDLRKKMSII PQEPVLFTGT MRKNLDPFNE
     HSDEELWKAL EEVQLKEAIE DLPGKMDTEL AESGSNFSVG QRQLVCLARA ILKKNRILII
     DEATANVDPR TDELIQQKIR EKFAQCTVLT IAHRLNTIID SDKIMVLDSG RLREYDEPYV
     LLQNPESLFY KMVQQLGKGE AAALTETAKQ VYFRRNYPDI AFSSPAVMST SNGQPSALTI
     FETAL
//
